Sputnik V Covid-19 vaccine candidate.Dr Reddy’s Laboratories Ltd had last week applied to the Drugs Controller General of India (DCGI) for an emergency licence for the Russian vaccine.
It had partnered with the Russian Direct Investment Fund (RDIF) in September 2020 to conduct clinical trials for Sputnik V.Also Read | Bitter home truths for migrant workersThe lab is currently conducting a phase 2 and 3 bridging study with around 1,500 participants, aimed at proving that the vaccine provides protection in the Indians.A phase 3 study in Russia, published in The Lancet, showed the vaccine had an efficacy of 91.6%.